Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab
Clinical trial NCT05972967 · COMPLETED
Trial details
- NCT number
- NCT05972967
- Sponsor
- Omeros Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2024-10-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.